These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 22809538)

  • 21. Implantable cardioverter defibrillator therapy in adults with congenital heart disease: who is at risk of shocks?
    Koyak Z; de Groot JR; Van Gelder IC; Bouma BJ; van Dessel PF; Budts W; van Erven L; van Dijk AP; Wilde AA; Pieper PG; Sieswerda GT; Mulder BJ
    Circ Arrhythm Electrophysiol; 2012 Feb; 5(1):101-10. PubMed ID: 22095638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.
    Whang W; Mittleman MA; Rich DQ; Wang PJ; Ruskin JN; Tofler GH; Muller JE; Albert CM;
    Circulation; 2004 Mar; 109(11):1386-91. PubMed ID: 14993132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clustering of poor device acceptance and Type D personality is associated with increased distress in Danish cardioverter-defibrillator patients.
    Pedersen SS; Spindler H; Johansen JB; Mortensen PT
    Pacing Clin Electrophysiol; 2009 Jan; 32(1):29-36. PubMed ID: 19140910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of implantable cardioverter-defibrillator on left ventricular ejection fraction in patients with idiopathic dilated cardiomyopathy.
    Schaer B; Theuns DA; Sticherling C; Szili-Torok T; Osswald S; Jordaens L
    Am J Cardiol; 2010 Dec; 106(11):1640-5. PubMed ID: 21094367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of chronic anxiety in implantable defibrillator patients: a multi-center study.
    Pedersen SS; den Broek KC; Theuns DA; Erdman RA; Alings M; Meijer A; Jordaens L; Denollet J
    Int J Cardiol; 2011 Mar; 147(3):420-3. PubMed ID: 19896732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clustering of device-related concerns and type D personality predicts increased distress in ICD patients independent of shocks.
    Pedersen SS; Theuns DA; Erdman RA; Jordaens L
    Pacing Clin Electrophysiol; 2008 Jan; 31(1):20-7. PubMed ID: 18181906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between left ventricular ejection fraction post-cardiac resynchronization treatment and subsequent implantable cardioverter defibrillator therapy for sustained ventricular tachyarrhythmias.
    Manfredi JA; Al-Khatib SM; Shaw LK; Thomas L; Fogel RI; Padanilam B; Rardon D; Vatthyam R; Gemma LW; Golden K; Prystowsky EN
    Circ Arrhythm Electrophysiol; 2013 Apr; 6(2):257-64. PubMed ID: 23443618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychological indices as predictors for phantom shocks in implantable cardioverter defibrillator recipients.
    Starrenburg A; Kraaier K; Pedersen S; Scholten M; Van Der Palen J
    Pacing Clin Electrophysiol; 2014 Jun; 37(6):768-73. PubMed ID: 24456312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial.
    Saxon LA; Bristow MR; Boehmer J; Krueger S; Kass DA; De Marco T; Carson P; DiCarlo L; Feldman AM; Galle E; Ecklund F
    Circulation; 2006 Dec; 114(25):2766-72. PubMed ID: 17159063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical prediction model for death prior to appropriate therapy in primary prevention implantable cardioverter defibrillator patients with ischaemic heart disease: the FADES risk score.
    van Rees JB; Borleffs CJ; van Welsenes GH; van der Velde ET; Bax JJ; van Erven L; Putter H; van der Bom JG; Schalij MJ
    Heart; 2012 Jun; 98(11):872-7. PubMed ID: 22581736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concerns about implantable cardioverter-defibrillator shocks mediate the relationship between actual shocks and psychological distress.
    Thylén I; Moser DK; Strömberg A; Dekker RA; Chung ML
    Europace; 2016 Jun; 18(6):828-35. PubMed ID: 26324839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atrial fibrillation predicts appropriate shocks in primary prevention implantable cardioverter-defibrillator patients.
    Smit MD; Van Dessel PF; Rienstra M; Nieuwland W; Wiesfeld AC; Tan ES; Anthonio RL; Van Veldhuisen DJ; Van Gelder IC
    Europace; 2006 Aug; 8(8):566-72. PubMed ID: 16864611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of diabetes mellitus on inappropriate and appropriate implantable cardioverter-defibrillator therapy and mortality in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT) Trial.
    Ruwald MH; Zareba W; Jons C; Zhang C; Ruwald AC; Olshansky B; McNitt S; Bloch Thomsen PE; Shoda M; Merkely B; Moss AJ; Kutyifa V
    Circulation; 2013 Aug; 128(7):694-701. PubMed ID: 23881862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Shock and patient preimplantation type D personality are associated with poor health status in patients with implantable cardioverter-defibrillator.
    Pedersen SS; Tekle FB; Hoogwegt MT; Jordaens L; Theuns DA
    Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):373-80. PubMed ID: 22570357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Type-D personality but not implantable cardioverter-defibrillator indication is associated with impaired health-related quality of life 3 months post-implantation.
    Pedersen SS; Theuns DA; Muskens-Heemskerk A; Erdman RA; Jordaens L
    Europace; 2007 Aug; 9(8):675-80. PubMed ID: 17434891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analyses of inappropriate shocks in a Spanish ICD primary prevention population: Predictors and prognoses.
    Fernández-Cisnal A; Arce-León Á; Arana-Rueda E; Rodríguez-Mañero M; González-Cambeiro C; Moreno-Arribas J; Gaztañaga L; Castillo Poyo R; Cabanas-Grandío P; Arias MA; Andrés de la Huerta A; Sánchez Gómez JM; Martínez-Sande L; Pedrote A
    Int J Cardiol; 2015 Sep; 195():188-94. PubMed ID: 26046421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic importance of atrial fibrillation in implantable cardioverter-defibrillator patients.
    Borleffs CJ; van Rees JB; van Welsenes GH; van der Velde ET; van Erven L; Bax JJ; Schalij MJ
    J Am Coll Cardiol; 2010 Mar; 55(9):879-85. PubMed ID: 20185038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of ventricular arrhythmia after implantable defibrillator treatment in anxious type D patients.
    van den Broek KC; Nyklícek I; van der Voort PH; Alings M; Meijer A; Denollet J
    J Am Coll Cardiol; 2009 Aug; 54(6):531-7. PubMed ID: 19643315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.